Skip to content

Multicenter prospective randomized controlled clinical trial for the treatment of masseter hypoplasia in hemifacial microsomia

Multicenter prospective randomized controlled clinical trial for the treatment of masseter hypoplasia in hemifacial microsomia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017018
Enrollment
Unknown
Registered
2018-07-08
Start date
2018-07-12
Completion date
Unknown
Last updated
2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemifacial microsomia

Interventions

Experiment Group:NMES
Control Group:excercise

Sponsors

Shanghai 9th People's Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 60 Years

Inclusion criteria

Inclusion criteria: Hemifacial microsomia, diagnosed hypoplastic and abnormal in masseter muscles (the volume relative difference is over 30%), age 2-60 years, given informed consent

Exclusion criteria

Exclusion criteria: Other syndrome; Less than half a year before or after mandibular osteotomy and distraction surgery; NMES contraindication;

Design outcomes

Primary

MeasureTime frame
EMG data;

Countries

China

Contacts

Public ContactGang Chai

Shanghai 9th People's Hospital, Shanghai Jiao Tong University School of Medicine

13918218178@163.com+86 13918218178

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026